BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 31698791)

  • 1. Cell-Free DNA Methylation Profiling Analysis-Technologies and Bioinformatics.
    Huang J; Wang L
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31698791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
    Luo H; Wei W; Ye Z; Zheng J; Xu RH
    Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
    Gai W; Sun K
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational challenges in detection of cancer using cell-free DNA methylation.
    Sharma M; Verma RK; Kumar S; Kumar V
    Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
    Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
    Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
    Galardi F; Luca F; Romagnoli D; Biagioni C; Moretti E; Biganzoli L; Leo AD; Migliaccio I; Malorni L; Benelli M
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33334040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel technologies in cfDNA analysis and potential utility in clinic.
    Li J; Xu M; Peng J; Wang J; Zhao Y; Wu W; Lan X
    Chin J Cancer Res; 2021 Dec; 33(6):708-718. PubMed ID: 35125814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital Droplet PCR for Monitoring Tissue-Specific Cell Death Using DNA Methylation Patterns of Circulating Cell-Free DNA.
    Shemer R; Magenheim J; Dor Y
    Curr Protoc Mol Biol; 2019 Jun; 127(1):e90. PubMed ID: 31237424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer.
    Huang CC; Du M; Wang L
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Longing' for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing.
    Yu SCY; Choy LYL; Lo YMD
    Mol Diagn Ther; 2023 Sep; 27(5):563-571. PubMed ID: 37474843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems.
    Zhang L; Li J
    Clin Epigenetics; 2023 Oct; 15(1):168. PubMed ID: 37858233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA.
    Barefoot ME; Loyfer N; Kiliti AJ; McDeed AP; Kaplan T; Wellstein A
    Front Genet; 2021; 12():671057. PubMed ID: 34386036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
    Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
    Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.
    Ng CKY; Di Costanzo GG; Terracciano LM; Piscuoglio S
    Front Med (Lausanne); 2018; 5():78. PubMed ID: 29632864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA.
    Huang J; Soupir AC; Schlick BD; Teng M; Sahin IH; Permuth JB; Siegel EM; Manley BJ; Pellini B; Wang L
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling genome-wide DNA methylation.
    Yong WS; Hsu FM; Chen PY
    Epigenetics Chromatin; 2016; 9():26. PubMed ID: 27358654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
    Jiang P; Chan KCA; Lo YMD
    J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.